These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 16874667)
1. Telomeres and telomerase. A survey about methods and recent advances in cancer diagnostic and therapy. Weise JM; Günes C Histol Histopathol; 2006 Nov; 21(11):1249-61. PubMed ID: 16874667 [TBL] [Abstract][Full Text] [Related]
2. [Telomeres and telomerase as targeted therapies in cancer treatment]. Souiden Y; Bouraoui A; Chaieb K; Mahdouani K Bull Cancer; 2010 Sep; 97(9):1087-104. PubMed ID: 20663741 [TBL] [Abstract][Full Text] [Related]
3. Telomerase and cancer therapeutics. Harley CB Nat Rev Cancer; 2008 Mar; 8(3):167-79. PubMed ID: 18256617 [TBL] [Abstract][Full Text] [Related]
4. Telomere maintenance as a target for drug discovery. Sekaran V; Soares J; Jarstfer MB J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596 [TBL] [Abstract][Full Text] [Related]
5. Telomerase: a potential diagnostic and therapeutic tool in canine oncology. Argyle DJ; Nasir L Vet Pathol; 2003 Jan; 40(1):1-7. PubMed ID: 12627707 [TBL] [Abstract][Full Text] [Related]
6. Telomeres, telomerase and cancer: an up-date. Dhaene K; Van Marck E; Parwaresch R Virchows Arch; 2000 Jul; 437(1):1-16. PubMed ID: 10963374 [TBL] [Abstract][Full Text] [Related]
7. Harnessing telomerase in cancer therapeutics. Fakhoury J; Nimmo GA; Autexier C Anticancer Agents Med Chem; 2007 Jul; 7(4):475-83. PubMed ID: 17630922 [TBL] [Abstract][Full Text] [Related]
8. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies. Babizhayev MA; Yegorov YE J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007 [TBL] [Abstract][Full Text] [Related]
9. Telomeres and telomerase: understanding basic structure and potential new therapeutic strategies targeting it in the treatment of cancer. Sekhri K J Postgrad Med; 2014; 60(3):303-8. PubMed ID: 25121374 [TBL] [Abstract][Full Text] [Related]
11. Targeting telomerase. Siddiqa A; Cavazos DA; Marciniak RA Rejuvenation Res; 2006; 9(3):378-90. PubMed ID: 16859479 [TBL] [Abstract][Full Text] [Related]
12. Telomerase: is it the future diagnostic and prognostic tool in human cancer? Mabruk MJ; O'Flatharta C Expert Rev Mol Diagn; 2005 Nov; 5(6):907-16. PubMed ID: 16255632 [TBL] [Abstract][Full Text] [Related]
13. The roles of telomeres and telomerase in cellular immortalization and the development of cancer. Klingelhutz AJ Anticancer Res; 1999; 19(6A):4823-30. PubMed ID: 10697595 [TBL] [Abstract][Full Text] [Related]
14. Telomere maintenance in clinical medicine. Ulaner GA Am J Med; 2004 Aug; 117(4):262-9. PubMed ID: 15308436 [TBL] [Abstract][Full Text] [Related]
15. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease. Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999 [TBL] [Abstract][Full Text] [Related]
16. Determination of telomerase activity and telomere length. Wu KD; Moore MA Methods Mol Med; 2005; 113():207-23. PubMed ID: 15968105 [TBL] [Abstract][Full Text] [Related]
17. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Blackburn EH; Greider CW; Szostak JW Nat Med; 2006 Oct; 12(10):1133-8. PubMed ID: 17024208 [No Abstract] [Full Text] [Related]
18. Telomerase and cancer. Harley CB; Kim NW Important Adv Oncol; 1996; ():57-67. PubMed ID: 8791128 [TBL] [Abstract][Full Text] [Related]